Infection Prevention Market Report 2026

The infection prevention market size has grown steadily in recent years. It will grow from $44.87 billion in 2025 to $46.52 billion in 2026 at a compound annual growth rate (CAGR) of 3.7%. The growth in the historic period can be attributed to global outbreaks of infectious diseases, increasing awareness of personal hygiene, growth in healthcare-associated infections, expansion of healthcare infrastructure, regulatory enforcement of infection prevention standards.

The infection prevention market size is expected to see steady growth in the next few years. It will grow to $53.88 billion in 2030 at a compound annual growth rate (CAGR) of 3.7%. The growth in the forecast period can be attributed to rising public health awareness, increasing investment in preventive healthcare, expansion of healthcare facilities in emerging markets, growing demand for ppe and consumables, strengthening government preparedness programs. Major trends in the forecast period include increased adoption of preventive hygiene practices, rising demand for personal protective equipment, expansion of infection prevention beyond healthcare settings, growing emphasis on vaccination and immunization programs, standardization of infection prevention protocols.

The rising incidence of hospital-acquired infections is expected to drive the growth of the infection prevention market in the coming years. Hospital-acquired infections (HAIs) are infections that patients contract while receiving medical care in hospitals or other healthcare facilities. Infection prevention strategies address HAIs by implementing measures designed to minimize infection risks and enhance patient safety. For example, data from the third Point Prevalence Survey (PPS) conducted in 2022-2023 by the European Centre for Disease Prevention and Control (ECDC), a Sweden-based government agency, indicate that approximately 4.3 million patients in EU/EEA hospitals acquire at least one HAI each year. Consequently, the growing incidence of HAIs is fueling demand for infection prevention solutions.

Key companies in the infection prevention market are introducing innovative solutions, such as infection preventionist staffing calculators, to provide more reliable services to healthcare facilities. An infection preventionist staffing calculator estimates the required number of infection preventionists in a facility based on factors such as bed count, patient acuity, and facility type. For instance, in December 2023, the Association for Professionals in Infection Control and Epidemiology (APIC), a US-based organization focused on advancing infection prevention practices, launched such a staffing calculator. This tool helps hospitals and clinics determine the optimal number of infection preventionists (IPs), enhancing patient safety through proper staffing. Facility data will further refine the tool to provide precise staffing guidance.

In January 2023, Applied UV, Inc., a US-based disinfection technology company, acquired Puro Lighting for an undisclosed sum. This acquisition allows Applied UV to leverage Puro Lighting’s established commercial relationships, including partnerships with Acuity Brands, Ushio, and Johnson Controls. Puro Lighting is a US-based medical equipment manufacturer specializing in UV light disinfection technologies.

Major companies operating in the infection prevention market are Cardinal Health Inc., 3M Company, Stryker Corporation, Reckitt Benckiser Group plc, Ecolab Inc., B. Braun Melsungen AG, The Clorox Company, Olympus Corporation, Fortive Corporation, Steris PLC, Getinge AB, Sotera Health Inc., Belimed AG, Coltene Group, Steelco S.p.A., Skytron LLC, Melag Medizintechnik GmbH & Co. KG, Metrex Research, Pal International, Cisa Production S.r.l. Unipersonale, Covalon Technologies Ltd., Biosafe Systems LLC, Terragene SA, Micro-Scientific LLC, Matachana SA.

North America was the largest region in the infection prevention market in 2025. The regions covered in the infection prevention market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the infection prevention market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs have impacted the infection prevention market by increasing costs of sterilization equipment, disinfectors, and consumables such as ppe and chemical agents sourced globally. These impacts are most evident in consumables and equipment segments, particularly across asia-pacific and europe where import dependence is high. Elevated tariffs have raised procurement costs for hospitals, laboratories, and pharmaceutical companies. However, tariffs are also encouraging domestic manufacturing, localized supply chains, and innovation in cost-effective infection prevention solutions, supporting long-term market sustainability.

The infection prevention market research report is one of a series of new reports that provides infection prevention market statistics, including infection prevention industry global market size, regional shares, competitors with a infection prevention market share, detailed infection prevention market segments, market trends and opportunities, and any further data you may need to thrive in the infection prevention industry. This infection prevention market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Infection prevention involves measures and practices designed to reduce the risk and spread of infectious diseases. These practices include hygiene protocols such as handwashing, vaccination, and the use of protective equipment. They are essential in healthcare facilities, public spaces, and personal care settings to safeguard both individual and public health.

The primary product types for infection prevention include sterilization equipment, disinfectors, and consumables. Sterilization equipment comprises devices used to eliminate all forms of microbial life - including bacteria, viruses, and spores - from surfaces, fluids, medications, or biological culture media. Infection prevention targets various types of infections, including microbial infections and healthcare-associated infections (HAIs). These products are used by a range of end users, including hospitals and clinics, pharmaceutical companies, clinical laboratories, medical device manufacturers, the life sciences sector, and academic and research institutions.

The infection prevention market consists of revenues earned by entities by providing services such as disinfection, sterilization, and isolation precautions. The market value includes the value of related goods sold by the service provider or included within the service offering. The infection prevention market consists of sales of hand hygiene products, personal protective equipment (PPE), antimicrobial wipes and sprays, sharps disposal containers, and biohazard bags. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.